Clinical Trial Update: Impact of Low Dose Unfractionated Heparin Treatment on Inflammation in Sepsis [Phase 3]

View source ↗

Summary

Phase 3 trial assessing the impact of low-dose unfractionated heparin on inflammation in sepsis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sepsis
• Septic Shock

Drugs mentioned

• Unfractionated Heparin (unfractionated heparin)

Snippet

Sponsor: Indonesia University | Conditions: Severe Sepsis With Septic Shock, Severe Sepsis Without Septic Shock | Phase 3 | Status: COMPLETED